Key result
Medications aimed at reducing renin and sympathetic activity may improve cardiovascular prognosis in hemodialysis patients independent of their effect on blood pressure.
Why the study?
Do medications aimed at reducing renin and sympathetic activity improve cardiovascular prognosis in hemodialysis patients?
Do medications aimed at reducing renin and sympathetic activity improve cardiovascular prognosis in hemodialysis patients?
Medications targeting the renin-angiotensin and sympathetic nervous systems may improve cardiovascular prognosis in hemodialysis patients independent of blood pressure reduction.
No takes yet. Share an insight, caveat, or question.
May support renin/sympathetic inhibition for CV benefit in hemodialysis beyond BP control; leaves open confirmation in prospective RCTs.
Blankestijn et al. (2004) studied this question. Medications aimed at reducing renin and sympathetic activity may improve cardiovascular prognosis in hemodialysis patients independent of their effect on blood pressure.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: